Lei Xiang
- Genetics top 10%
- Mesenchymal stem cell research 5
- Virus-based gene therapy research 1
-
- Cancer-related molecular mechanisms research 2
-
- Bone Metabolism and Diseases 1
-
- Nerve injury and regeneration 2
-
- Acute Myeloid Leukemia Research 1
-
- Ocular Infections and Treatments 1
-
- Radiopharmaceutical Chemistry and Applications 1
- Co-authors
- Di WuBing‐Dong SuiYu FuSongtao ShiXiaoxing KouXiao ZhangJihua ChenJun Zhou
- Cited by
- GeneticsImmunologyCancer Research
- Partner nations
- ChinaUnited States
In The Last Decade
Lei Xiang
17 papers receiving 513 citations
Peers
Comparison fields: 5 of 79
- Genetics 136
- Immunology 118
- Cancer Research 77
- Molecular Biology 280
- Urology 25
Countries citing papers authored by Lei Xiang
This map shows the geographic impact of Lei Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Xiang more than expected).
Fields of papers citing papers by Lei Xiang
This network shows the impact of papers produced by Lei Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Xiang. The network helps show where Lei Xiang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lei Xiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 20 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 12 | |
| 8 | 2022 | 9 | |
| 9 | 2022 | 0 | |
| 10 | 2021 | 68 | |
| 11 | 2021 | 159 | |
| 12 | 2021 | 2 | |
| 13 | 2020 | 99 | |
| 14 | 2019 | 31 | |
| 15 | 2018 | 8 | |
| 16 | 2015 | 72 | |
| 17 | 2014 | 18 | |
| 18 | Efficient multicistronic co-expression of hNIS and hTPO in prostate cancer cells for nonthyroidal tumor radioiodine therapy. | 2012 | 1 |
| 19 | [Cell surface antigen expression of orbital preadipocytes between patients with thyroid-associated ophthalmopathy and healthy adults]. | 2008 | 1 |
About Lei Xiang
Lei Xiang is a scholar working on Genetics, Complementary and Manual Therapy and Cancer Research, having authored 19 papers that have together received 517 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (5 papers), Nerve injury and regeneration (2 papers), Cancer-related molecular mechanisms research (2 papers), Bone Metabolism and Diseases (1 paper), Acute Myeloid Leukemia Research (1 paper), Ocular Infections and Treatments (1 paper), Virus-based gene therapy research (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Genetics (136 citations), Immunology (118 citations) and Cancer Research (77 citations). Lei Xiang has collaborated with scholars based in China and United States. Frequent co-authors include Di Wu, Bing‐Dong Sui, Yu Fu, Songtao Shi, Xiaoxing Kou, Songtao Shi, Xiao Zhang, Jihua Chen, Jun Zhou and Siying Liu. Their work appears in journals such as ACS Nano, Cancer Letters and Journal of Endodontics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.